Patents by Inventor Kun-Liang Wu

Kun-Liang Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230002440
    Abstract: Improved processes for the preparation of tubulysin compounds, tubulysin drug linker compounds, and their intermediates are disclosed.
    Type: Application
    Filed: September 6, 2019
    Publication date: January 5, 2023
    Applicant: Seattle Genetics, Inc.
    Inventors: Kun-Liang WU, Qingwu JIN, Wendel DOUBLEDAY
  • Publication number: 20220323601
    Abstract: Improved processes for the preparation of tubulysin compounds, tubulysin drug linker compounds, and their intermediates are disclosed.
    Type: Application
    Filed: June 8, 2022
    Publication date: October 13, 2022
    Inventors: Kun-Liang WU, Qingwu JIN, Wendel DOUBLEDAY
  • Patent number: 11389543
    Abstract: Improved processes for the preparation of tubulysin compounds, tubulysin drug linker compounds, and their intermediates are disclosed.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: July 19, 2022
    Assignee: Seagen Inc.
    Inventors: Kun-Liang Wu, Qingwu Jin, Wendel Doubleday
  • Publication number: 20200297864
    Abstract: Improved processes for the preparation of tubulysin compounds, tubulysin drug linker compounds, and their intermediates are disclosed.
    Type: Application
    Filed: September 7, 2018
    Publication date: September 24, 2020
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Kun-Liang Wu, Qingwu Jin, Wendel Doubleday